Biomea Fusion Stock Quote BMEA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.55

Bid

5.26

Ask

5.72

Volume

315,166

5.33 Day's Range 5.63

3.61 52 Week Range 23.03

Market Cap

199.492M

Previous Close

5.46

Open

5.59

Last Trade

5.65

Last Trade Time

Financial Volume

$ 1,729,679

VWAP

5.4882

Average Volume (3m)

1,314,809

Shares Outstanding

35,944,584

Dividend Yield

PE Ratio

-1.70

Earnings Per Share (EPS)

-3.26

Revenue

Net Profit

-117.26M

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.biomeafusion.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Biomea Fusion Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BMEA. The last closing price for Biomea Fusion was $5.46. Over the last year, Biomea Fusion shares have traded in a share price range of $ 3.61 to $ 23.03.

Biomea Fusion currently has 35,944,584 shares outstanding. The market capitalization of Biomea Fusion is $196.26 million. Biomea Fusion has a price to earnings ratio (PE ratio) of -1.70.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold

REDWOOD CITY, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), announced that the Company has received notice from the U.S. Food and Drug...

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and...

Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes

REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral...

Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights

Reported positive data from the escalation portion of Phase 1/2 study (COVALENT-111) in type 2 diabetes patients, displaying durable improved glycemic control while off therapy for 22 weeks...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.38	7.3500967118	5.17	5.67	5	284991	5.41320188	CS
4	1.09	24.4394618834	4.46	5.83	4.15	549106	4.92560462	CS
12	-7.28	-56.7420109119	12.83	13.43	3.61	1314809	6.42413367	CS
26	-11.45	-67.3529411765	17	20.21	3.61	1150682	10.75467591	CS
52	-13.86	-71.4064914992	19.41	23.03	3.61	1002612	12.44549492	CS
156	-7.81	-58.4580838323	13.36	43.69	2.84	538616	16.22715911	CS
260	-14.45	-72.25	20	43.69	2.84	506743	16.24647932	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M